Delivery Order SPE2DB24D1107-SPE2DB24FZFP8
Award Date
8/26/24
Potential Completion Date
8/27/24
Potential Value
$1.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with an ID of SPE2DB20D2104|SPE2DB24FU37J, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HUMALOG 100 UNIT/ML VIAL 10ML, a type of insulin medication, with a ceiling value of $1,092.96 and a completion date of May 28, 2024. The contract is a Delivery Order under a Firm Fixed Price arrangement, with no set-aside designation...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,092.96 firm fixed-price delivery order is for the supply of HUMALOG 100 UNIT/ML VIAL 10ML, a medication used to treat diabetes. The contract has an ultimate completion date of May 8, 2023 and was awarded on May 5, 2023. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,821.60 Firm Fixed Price Delivery Order is for the supply of HUMALOG 100 UNIT/ML VIAL 10ML, a type of insulin medication. The contract has an ultimate completion date of August 23, 2024 and was awarded on August 22, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a Delivery Order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,413.30, is for the supply of HUMALOG 100 UNIT/ML VIAL 10ML, a type of insulin medication. The contract has a firm fixed price pricing type and an ultimate completion date of December 4, 2024. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for Award Management...
This federal contract award SPE2DB20D3101|SPE2DB24FRQU5 was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,366.20 firm fixed price delivery order is for the supply of HUMALOG 100 UNIT/ML VIAL 10ML, a prescription insulin medication. The contract has an ultimate completion date of July 25, 2024 and is not designated with any set-aside requirements, indicating open competition....
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,366.20 Firm Fixed Price contract is for the delivery of HUMALOG 100 UNIT/ML VIAL 10ML, a diabetes medication. This is a Delivery Order issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,413.30, is a delivery order for the supply of HUMALOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product. The contract has an ultimate completion date of March 19, 2025 and is a firm fixed-price contract. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,540.14 and is for the delivery of HUMALOG 100 UNIT/ML VIAL 10ML, a type of insulin medication. The contract has a firm fixed price pricing type and an ultimate completion date of December 27, 2024. The contract was awarded on December 26, 2024 and does not have a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,947.76, is for the delivery of Humalog 100 Unit/mL Vial 10mL, a type of insulin medication. This is a firm fixed-price delivery order contract with a completion date of November 6, 2024. The contract was not set aside for any specific business type. AmerisourceBergen holds a significant...
This federal contract award, with ID SPE2DB20D3103|SPE2DB21FQ0F6, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,815.80 firm fixed-price delivery order is for the supply of HUMALOG 100 UNIT/ML VIAL 10ML, a type of insulin medication. The contract is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent...